Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden of Hepatitis C in Iran Between 1990 and 2010: Findings From the Global Burden of Disease Study 2010 Pubmed



Shalmani HM1, 2 ; Noori A2, 3 ; Shokoohi M4 ; Khajavi A2, 3 ; Darvishi M5 ; Delavari A6 ; Jamshidi HR7 ; Naderimagham S2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Regional Knowledge Hub, and WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Infectious Diseases and Tropical Medicine Research Center (IDTMRC), AJA University of Medical Sciences, Tehran, Iran
  6. 6. Digestive Oncology Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. School of Medicine, Department of Pharmacology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Archives of Iranian Medicine Published:2015


Abstract

Background: Hepatitis C virus (HCV) is the foremost cause of deaths attributable tocirrhosis and hepatocellular carcinoma. The Global Burden of Disease (GBD) study from 2010 quantifies and compares the degree of health loss as a result of diseases, injuries, and risk factors by age, sex, and geography overtime. This study aimed to present and critique the burden of hepatitis C and its trend in Iran between 1990 and 2010 by using the GBD 2010 study. Methods: We used results of GBD 2010 between 1990 and 2010 for Iran to measure rates and trends for mortality, causes of deaths, years of life lost (YLLs), years lived with disability (YLDs), anddisability-adjusted lifeyears (DALYs). Hepatitis C was defined as the presence of hepatitis C virus in the serum. Data were presented in three categories: acute hepatitis C, cirrhosis secondary to hepatitis C, and liver cancer secondary to hepatitis C. Results: HCV infection (including the three categories of the study) led to 57.29, 59.92, and 66.45 DALYs (per 100,000 population) in 1990, 2000, and 2010, respectively. DALYs and death rates showed a slight decreasing trend for HCV cirrhosis; however, DALYs and death rates increased for acute hepatitis and liver cancer due to patients with HCV. The majority of deaths and DALYs were in individuals aged 70 years and above in all three categories of HCV. YLLs made the greatest contributions to DALYs. Conclusion: DALYs due to HCV infection are increasing in Iran according to GBD 2010; however, the estimations of DALYs using GBD 2010 are mostly from model-based data and there are significant uncertainties for extrapolated data. In this regard, acomprehensive study such asthe National and Subnational Burden of Diseases (NASBOD) study would be needed to estimate and calculate precisely prevalence and burden of HCV-related disease at national and subnational levels. © 2015, Academy of Medical Sciences of I.R. Iran. All rights reserved.
Related Docs
View other Related Docs
1. The Most Prevalent Causes of Deaths, Dalys, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
2. Burden of Disease Attributable to Vitamin a Deficiency in Iranian Population Aged Less Than Five Years: Findings From the Global Burden of Disease Study 2010, Journal of Diabetes and Metabolic Disorders (2017)
3. Burden of Malaria in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2016)
4. Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6pd Deficiency) in Iran, 1990–2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
5. A Burden Assessment of Occupational Exposures in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, International Journal of Preventive Medicine (2018)
6. A Systematic Review of Studies on Blood Pressure in Iranian Pediatric Population: First Report From the Middle East and North Africa, Iranian Journal of Pediatrics (2016)
7. Burden of Ischemic Heart Disease Attributable to Low Omega-3 Fatty Acids Intake in Iran: Findings From the Global Burden of Disease Study 2010, Journal of Tehran University Heart Center (2016)
8. Burden of Ischemic Heart Diseases in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Journal of Research in Medical Sciences (2015)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (29)
Shohreh Naderimagham (20)
Other Related Docs
9. Burden of Oral Diseases in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
10. The Global Burden of Cancer 2013, JAMA Oncology (2015)
11. Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
12. Trends in Health Burden of Ambient Particulate Matter Pollution in Iran, 1990–2010: Findings From the Global Burden of Disease Study 2010, Environmental Science and Pollution Research (2015)
13. Burden of Cancers in Iran From 1990 to 2010: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
14. The Burden of Hiv in Iran: Insights From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2016)
15. Burden of Drug and Alcohol Use Disorders in Iran: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
16. Burden of Vaccine-Preventable Diseases—Measles, Tetanus, Diphtheria and Whooping Cough—In Iran: Findings From the Gbd Study 2010, Archives of Iranian Medicine (2016)
17. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale), 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
18. Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)
19. Prevalence of Hepatitis C Infection in Iranian Hemodialysis Patients: An Updated Systematic Review and Meta-Analysis, Journal of Research in Medical Sciences (2017)
20. Trends in Health Burden of Untreated Water and Insanitary Environments in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Medical Journal of the Islamic Republic of Iran (2016)
21. Twenty-Six-Year Trend of Mortality Rate Due to Ischemic Heart Diseases (Ihds) in Iran: 1990-2015, Iranian Journal of Public Health (2022)
22. The Burden of Leishmaniasis in Iran, Acquired From the Global Burden of Disease During 1990-2010, Asian Pacific Journal of Tropical Disease (2017)
23. High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25-64 Years Old Iranian Population, International Journal of Preventive Medicine (2016)
24. Annual Trends of Gastrointestinal Cancers Mortality in Iran During 1990-2015; Nasbod Study, Archives of Iranian Medicine (2018)
25. Burden of Sexually Transmitted Infections in Iran From 1990 to 2010: Results From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2016)
26. Liver Cirrhosis Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis, PLoS ONE (2019)
27. Global, Regional, and National Disability-Adjusted Life Years (Dalys) for 306 Diseases and Injuries and Healthy Life Expectancy (Hale) for 188 Countries, 1990-2013: Quantifying the Epidemiological Transition, The Lancet (2015)
28. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
29. World Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data Synthesis, PLoS Medicine (2015)
30. A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents, Iranian Journal of Pediatrics (2016)
31. Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology, International Journal of Preventive Medicine (2015)
32. The Trend of Burn Mortality in Iran — a Study of Fire, Heat and Hot Substance-Related Fatal Injuries From 1990 to 2015, Burns (2019)
33. Mortality Attributable to Nutritional Deficiencies Among Iranian Children Under the Age of Five at National and Sub-National Level: 1995-2015, Archives of Iranian Medicine (2020)
34. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
35. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
36. Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)
37. National and Subnational Trends in Incidence and Mortality of Lung Cancer in Iran From 1990 to 2016, Asia-Pacific Journal of Clinical Oncology (2020)
38. Trends of Diabetes Mortality in Iran at National and Sub-National Levels From 1990 to 2015 and Its Association With Socioeconomic Factors, Medical Journal of the Islamic Republic of Iran (2022)
39. Hepatitis C Virus Infection in Iran: A Review of Current Prevalence and Preventive Strategies From a Developing Country, Journal of Clinical Virology Plus (2024)
40. Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale) in Iran and Its Neighboring Countries, 1990–2015: Findings From Global Burden of Disease Study 2015, Archives of Iranian Medicine (2017)
41. Estimation of Burden of Ischemic Heart Diseases in Isfahan, Iran, 2014: Using Incompleteness and Misclassification Adjustment Models, Journal of Diabetes and Metabolic Disorders (2017)
42. Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A Ns5b Phylogenetic Analysis With Systematic Review, Hepatitis Monthly (2016)
43. Measuring Iran's Success in Achieving Millennium Development Goal 4: A Systematic Analysis of Under-5 Mortality at National and Subnational Levels From 1990 to 2015, The Lancet Global Health (2017)
44. Mortality and Years of Life Lost Due to Burn Injury Among Older Iranian People; a Cross-Sectional Study, Archives of Academic Emergency Medicine (2022)
45. The Mortality Rate From Self-Harm in Iran, Public Health (2020)
46. Update on the Prevalence of Hepatitis C Virus Infection Among Iranian General Population: A Systematic Review and Meta-Analysis, Hepatitis Monthly (2017)
47. Trend of Fatal Poisoning at National and Provincial Levels in Iran From 1990 to 2015, Public Health (2019)
48. Prevalence of Dyslipidemia in Iranian Children and Adolescents: A Systematic Review, Journal of Research in Medical Sciences (2015)
49. Prevalence of Hepatitis C Virus Infection Among High-Risk Groups in Iran: A Systematic Review and Meta-Analysis, Public Health (2018)
50. Iran to Achieve the Sdg 3.4 at National and Sub-National Levels, Scientific Reports (2022)